Treatment Options for Dementia with Lewy Bodies: A Network Meta-Analysis of Randomised Control Trials
Abstract Introduction Dementia with Lewy bodies (DLB) is the third most common type of dementia after Alzheimer’s disease (AD) and vascular dementia. Treatment is targeted at specific disease manifestations/symptoms. While donepezil is approved for the treatment of DLB in Japan, to date no other tre...
Main Authors: | Amir A. Tahami Monfared, Mitesh Desai, Robert Hughes, Stefano Lucherini, Yunni Yi, Richard Perry |
---|---|
Format: | Article |
Language: | English |
Published: |
Adis, Springer Healthcare
2020-06-01
|
Series: | Neurology and Therapy |
Subjects: | |
Online Access: | https://doi.org/10.1007/s40120-020-00198-0 |
Similar Items
-
Neuropsychiatric symptoms
in patients with vascular
dementia in mainland China
by: Jin Yan-ling, et al.
Published: (2015-01-01) -
What is the impact of regulatory guidance and expiry of drug patents on dementia drug prescriptions in England? A trend analysis in the Clinical Practice Research Datalink
by: Venexia M. Walker, et al.
Published: (2018-05-01) -
Relationship between Dementia Severity and Behavioral and Psychological Symptoms of Dementia in Dementia with Lewy Bodies and Alzheimer's Disease Patients
by: Mamoru Hashimoto, et al.
Published: (2015-06-01) -
Clinical and Cognitive Phenotype of Mild Cognitive Impairment Evolving to Dementia with Lewy Bodies
by: Annachiara Cagnin, et al.
Published: (2015-11-01) -
Safety of Cholinesterase Inhibitors and NMDA Receptors Antagonists for the Treatment of Patients with Dementia
by: A. P. Pereverzev, et al.
Published: (2019-12-01)